SRRK
Price
$46.60Alerts
Change
-$1.40 (-2.92%)
Updated
Nov 11 closing price
Capitalization
5.72B
117 days until earnings call
Intraday BUY SELL Signals
VERA
Price
$30.48Alerts
Change
+$0.45 (+1.50%)
Updated
Nov 11 closing price
Capitalization
2.15B
133 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SRRK vs VERA

SRRK vs VERA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SRRK vs. VERA commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRRK is a Hold and VERA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for SRRK with price predictions
Nov 11, 2026

Momentum Indicator for SRRK turns positive, indicating new upward trend

SRRK saw its Momentum Indicator move above the 0 level on October 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In 71 of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SRRK just turned positive on October 21, 2026. Looking at past instances where SRRK's MACD turned positive, the stock continued to rise in 38 of 49 cases over the following month. The odds of a continued upward trend are 78%.

Following a +13.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRRK advanced for three days, in 228 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The 10-day RSI Indicator for SRRK moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 21 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 51 of 54 cases where SRRK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

SRRK moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for SRRK moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRRK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

SRRK broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRRK entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SRRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.525) is normal, around the industry mean (3.498). P/E Ratio (-14.181) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for VERA with price predictions
Nov 11, 2026

VERA in upward trend: price may jump up because it broke its lower Bollinger Band on October 12, 2026

VERA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 30 cases where VERA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VERA's RSI Oscillator exited the oversold zone, 25 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for VERA just turned positive on October 20, 2026. Looking at past instances where VERA's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.

Following a +5.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where VERA advanced for three days, in 238 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 197 of 228 cases where VERA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 53 cases where VERA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VERA as a result. In 80 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

VERA moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.264) is normal, around the industry mean (3.498). P/E Ratio (-5.074) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. VERA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SRRKVERA
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (SRRK: $48.00 vs. VERA: $30.03)
Brand notoriety: SRRK and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRRK: 103% vs. VERA: 80%
Market capitalization -- SRRK: $5.72B vs. VERA: $2.15B
SRRK [@Biotechnology] is valued at $5.72B. VERA’s [@Biotechnology] market capitalization is $2.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRRK’s FA Score shows that 0 FA rating(s) are green while VERA’s FA Score has 1 green FA rating(s).

  • SRRK’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 1 green, 4 red.
According to our system of comparison, SRRK is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRRK’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • SRRK’s TA Score: 4 bullish, 6 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than SRRK.

Price Growth

SRRK (@Biotechnology) experienced а +9.14% price change this week, while VERA (@Biotechnology) price change was -2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.

Reported Earning Dates

SRRK is expected to report earnings on Mar 09, 2027.

VERA is expected to report earnings on Mar 25, 2027.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with RYTM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-2.92%
RYTM - SRRK
48%
Loosely correlated
-1.57%
PTGX - SRRK
44%
Loosely correlated
-1.03%
VERA - SRRK
43%
Loosely correlated
+1.50%
ARVN - SRRK
42%
Loosely correlated
-0.14%
CGON - SRRK
41%
Loosely correlated
-0.04%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with VKTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then VKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+1.50%
VKTX - VERA
44%
Loosely correlated
-0.77%
MGTX - VERA
42%
Loosely correlated
+0.62%
SRRK - VERA
42%
Loosely correlated
-2.92%
NAMS - VERA
41%
Loosely correlated
+8.03%
TRVI - VERA
41%
Loosely correlated
-0.64%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HIMZ11.321.68
+17.43%
Defiance Daily Target 2X Long HIMS ETF (HIMZ)
SLYG111.611.08
+0.98%
State Street SPDR S&P 600 Small Cap Growth ETF (SLYG)
SPXD30.650.18
+0.61%
Xtrackers S&P 500 Diversified Sector Weight ETF (SPXD)
BKHY45.770.09
+0.20%
BNY Mellon High Yield ETF (BKHY)
KIE65.70-0.13
-0.20%
State Street SPDR S&P Insurance ETF (KIE)